Begin main content

Plerixafor for Patients Failing Stem Cell Mobilization: Clinical and Cost-Effectiveness and Guidelines

Last updated: November 19, 2015
Project Number: RA0818-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

1. What is the clinical effectiveness of plerixafor for the treatment of patients who are failing or who have failed stem cell mobilization?

2. What is the cost-effectiveness of plerixafor for the treatment of patients who are failing or who have failed stem cell mobilization?

3. What are the evidence-based guidelines regarding the use of plerixafor for the treatment of patients who are failing or who have failed stem cell mobilization?

Key Message

Thirty-five non-randomized studies, five economic evaluations, and two evidence-based guidelines were identified regarding the use of plerixafor for the treatment of patients who are failing stem or who have failed cell mobilization.